March 16, 2022 at 11:00am Eastern Time
Discussion of the use of immunohistochemistry in the diagnosis of melanocytic tumors.
At the end of the webinar, participants will be able to:
- Provide an overview of the complex challenges in diagnostic melanocytic tumor pathology
- Discuss the benefit of individual immunohistochemical markers in specific diagnostic settings
Speaker: Thomas Brenn
Target audience: Pathologists, Residents, Medical Students
CanMEDS Roles: Medical Expert, Communicator
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the CAP-ACP. You may claim a maximum of 1.5 hours per event attended. (credits are automatically calculated).
This program is an accredited selfâassessment program (section 3) as defined by the maintenance of certification program of the royal college of physicians & surgeons of Canada and approved by the Canadian association of Pathologists. You may claim a maximum of 0.5 hours (credits are automatically calculated)
To qualify for Section 3
You must complete both the Pre-Test and Post-Test Self Assessment Questions and attend the webinar to qualify for 0.5 hour of Section 3 MOC and 1 hour of Section 1 MOC.